Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galapagos (GLPG)
NASDAQ:GLPG
Holding GLPG?
Track your performance easily
GLPG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$24.16 - $42.46
Previous Close$30.56
Volume59.78K
Average Volume (3M)153.34K
Market Cap
$2.03B
Enterprise Value-$2.01B
Total Cash (Recent Filing)€3.68B
Total Debt (Recent Filing)€41.64M
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Oct 30, 2024EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.32
Shares Outstanding65,897,071
10 Day Avg. Volume146,312
30 Day Avg. Volume153,344
Standard Deviation0.10
R-Squared0.01
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.72
Price to Sales (P/S)7.61
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$27.33Price Target Upside-9.74% Downside
Rating ConsensusHold
Number of Analyst Covering5
Galapagos News
PremiumCompany Announcements
Galapagos Unveils Promising Cancer Therapy Data
Bulls Say, Bears Say
Bulls Say
Clinical TrialsThe company has submitted an IND with the FDA to expand the ATALANTA trial to the U.S., indicating potential growth in new markets.
Research And DevelopmentGalapagos is advancing multiple Phase I/II CAR T programs in oncologic indications, with early data showing promising efficacy and clean safety profiles.
Strategic CollaborationsThe company has entered into a strategic collaboration with Global Blood Therapeutics to further expand its CAR-T production system in the region.
Bears Say
Clinical Trial IssuesEnrollment in '5301's PAPILIO-1 trial in MM was temporarily paused in the EU after a single case of Parkinsonism was observed.
Investor PerceptionInvestor perception is that the company’s current pipeline activities are likely value-destructive, as reflected by trading at ~50% of its cash on hand.
Pipeline RiskThe company's pipeline assets are seen as having high risk and questionable end-market value.
---
Ownership Overview
0.00%
Insiders
4.72% Mutual Funds
23.11% Other Institutional Investors
72.17% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GLPG FAQ
What was Galapagos’s price range in the past 12 months?
Galapagos lowest stock price was $24.16 and its highest was $42.45 in the past 12 months.
What is Galapagos’s market cap?
Currently, no data Available
When is Galapagos’s upcoming earnings report date?
Galapagos’s upcoming earnings report date is Oct 30, 2024 which is in 42 days.
How were Galapagos’s earnings last quarter?
Galapagos released its earnings results on Aug 01, 2024. The company reported $0.116 earnings per share for the quarter, beating the consensus estimate of -$0.074 by $0.19.
Is Galapagos overvalued?
According to Wall Street analysts Galapagos’s price is currently Overvalued.
Does Galapagos pay dividends?
Galapagos does not currently pay dividends.
What is Galapagos’s EPS estimate?
Galapagos’s EPS estimate is -$0.15.
How many shares outstanding does Galapagos have?
Galapagos has 65,897,070 shares outstanding.
What happened to Galapagos’s price movement after its last earnings report?
Galapagos reported an EPS of $0.116 in its last earnings report, beating expectations of -$0.074. Following the earnings report the stock price went down -5.095%.
Which hedge fund is a major shareholder of Galapagos?
Among the largest hedge funds holding Galapagos’s share is Deerfield Management Company, LP. It holds Galapagos’s shares valued at 35M.
---
Galapagos Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$27.33 (-9.74% Downside)
$27.33 (-9.74% Downside)
Blogger Sentiment
Bullish
GLPG Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 5.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-15.71%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-6.80%
Trailing 12-Months
Company Description
Galapagos
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
---
GLPG Company Deck
---
GLPG Earnings Call
Q2 2024
0:00 / 0:00
---
GLPG Stock 12 Month Forecast
Average Price Target
$27.33
▼(-9.74% Downside)
Technical Analysis
Best Analysts Covering GLPG
1 Year
1 Year Success Rate
8/14 ratings generated profit
1 Year Average Return
+19.34%
reiterated a buy rating 2 months ago
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +19.34% per trade.
---